ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The French contract research firm NovAliX will spend $6.4 million to expand its DNA-encoded library (DEL) platform as part of an 8-year deal with an unnamed drug company. NovAliX says the informatics-driven system designs and synthesizes DELs while capturing and tracking experimental information. NovAliX says it has hired medicinal chemists from a number of drug companies to run its DEL program.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X